[Effectiveness of peroral administration of aurantin in the treatment of Ehrlich carcinoma].
D000818:Animals; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000970:Antineoplastic Agents; D002286:Carcinoma, Ehrlich Tumor; D003609:Dactinomycin
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000970:Antineoplastic Agents; D003609:Dactinomycin; C090194:aurantin
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR